Formulation and in-vitro release studies of Ranibizumab (Lucentis) loaded liposomes
Poor drug delivery to the posterior segment in patients’ eyes is a major obstacle to the treatment of ocular diseases due to its physiological and chemical barriers for transport of large molecular weight molecules such as proteins. In the past few decades, considerable research has been directed to...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/51842 |